Severe acute malnutrition results in lower lumefantrine exposure in children treated with artemether‐lumefantrine for uncomplicated malaria

Severe acute malnutrition results in lower lumefantrine exposure in children treated with artemether‐lumefantrine for uncomplicated malaria

Severe acute malnutrition (SAM) has been reported to be associated with increased malaria morbidity in Sub‐Saharan African children and may affect the pharmacology of antimalarial drugs. This population pharmacokinetic (PK)‐pharmacodynamic study included 131 SAM and 266 non‐SAM children administered...

Description complète

Détails bibliographiques
Auteurs principaux:	Chotsiri, P, Denoeud-Ndam, L, Baudin, E, Guindo, O, Diawara, H, Attaher, O, Smit, M, Guerin, PJ, Doumbo, OK, Wiesner, L, Barnes, KI, Hoglund, RM, Dicko, A, Etard, J-F, Tarning, J
Format:	Journal article
Langue:	English
Publié:	American Society for Clinical Pharmacology and Therapeutics 2019

Documents similaires

Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger.
par: Denoeud-Ndam, L, et autres
Publié: (2016)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
par: Tarning, J, et autres
Publié: (2009)

Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria
par: Tchaparian, E, et autres
Publié: (2016)

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
par: Peto, TJ, et autres
Publié: (2022)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
par: Mcgready, R, et autres
Publié: (2006)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
par: McGready, R, et autres
Publié: (2009)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
par: Denis, M, et autres
Publié: (2006)

Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
par: Tarning, J, et autres
Publié: (2013)

Artemether-lumefantrine coadministration with antiretrovirals; population pharmacokinetics and dosing implications.
par: Hoglund, R, et autres
Publié: (2014)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.
par: Ali, S, et autres
Publié: (2010)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
par: White, N, et autres
Publié: (1999)

EFFICACY AND SAFETY OF QUININE VS. ARTEMETHER-LUMEFANTRINE IN UNCOMPLICATED MALARIA DURING PREGNANCY, MBARARA, UGANDA
par: Piola, P, et autres
Publié: (2009)

Population pharmacokinetics of artemether, dihydroartemisinin and lumefantrine in Rwandese pregnant women treated for uncomplicated Plasmodium falciparum malaria
par: Das, J, et autres
Publié: (2018)

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
par: White, N, et autres
Publié: (1999)

Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine in combination treatment of uncomplicated falciparum malaria in pediatric patients
par: Hietala, S, et autres
Publié: (2009)

Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos.
par: Mayxay, M, et autres
Publié: (2012)

Drug interactions between dolutegravir and artemether-lumefantrine or artesunate-amodiaquine
par: Walimbwa, S, et autres
Publié: (2018)

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
par: Tarning, J, et autres
Publié: (2022)

A randomised controlled trial of 3 versus 5 days artemether-lumefantrine regimen for uncomplicated Plasmodium falciparum treatment in pregnancy in Africa
par: Onyamboko, M, et autres
Publié: (2019)

No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine.
par: van Vugt, M, et autres
Publié: (1999)

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.
par: van Vugt, M, et autres
Publié: (2000)

Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.
par: Hietala, S, et autres
Publié: (2010)

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
par: Ashley, E, et autres
Publié: (2007)

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
par: Ashley, E, et autres
Publié: (2007)

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
par: Mcgready, R, et autres
Publié: (2008)

Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: A systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data
par: Ashley, E, et autres
Publié: (2015)

Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border
par: Kloprogge, F, et autres
Publié: (2015)

Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
par: Mwesigwa, J, et autres
Publié: (2010)

Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda.
par: Kloprogge, F, et autres
Publié: (2013)

EFFICACY OF ARTESUNATE-AMODIAQUINE (ASAQ) AND ARTEMETHER-LUMEFANTRINE (AL) FIXED DOSE COMBINATIONS (FDCS) FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM (PF) MALARIA IN NIMBA COUNTY, LIBERIA
par: Schramm, B, et autres
Publié: (2010)

Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether-lumefantrine in Kenya: a cluster randomized trial.
par: Skarbinski, J, et autres
Publié: (2009)

A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda.
par: Fanello, C, et autres
Publié: (2007)

Antimalarial resistance unlikely to explain U.K. artemether-lumefantrine failures
par: van der Pluijm, R, et autres
Publié: (2017)

Genomic characterization of recrudescent plasmodium malariae after treatment with artemether/lumefantrine
par: Rutledge, G, et autres
Publié: (2017)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
par: Sipilanyambe, N, et autres
Publié: (2008)

A case-control auditory evaluation of patients treated with artemether-lumefantrine.
par: Hutagalung, R, et autres
Publié: (2006)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
par: Zurovac, D, et autres
Publié: (2008)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
par: Zurovac, D, et autres
Publié: (2008)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.
par: Sipilanyambe, N, et autres
Publié: (2008)

Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial.
par: Piola, P, et autres
Publié: (2010)